Literature DB >> 8300620

Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins.

R S McLeod1, Y Zhao, S L Selby, J Westerlund, Z Yao.   

Abstract

Human apolipoprotein (apo) B plays an obligatory role in the assembly and secretion of hepatic triglyceride-rich lipoproteins. Investigation of the truncated human apoB variants associated with hypobetalipoproteinemia has suggested that both size and secretion of apoB-containing lipoproteins may be reduced by carboxyl-terminal truncation. To examine the role of the carboxyl terminus of apoB in the assembly and secretion of hepatic lipoproteins, we have generated rat hepatoma McA-RH7777 cells that synthesize and secrete the full-length human apoB100 and the truncated forms B94, B88, B80, B72, and B60. In the resulting lipoproteins, particle density was inversely related to the logarithm of apoB length, ranging from 1.019 g/ml for apoB100 to 1.06 g/ml for B60. Furthermore, particle diameter (as determined by non-denaturing gel electrophoresis) was directly correlated with apoB length, ranging from 21.4 nm for apoB100 to 17.7 nm for B60. The relationship between apoB length and particle geometry was best defined by a linear correlation between length and core volume; a 10% decrease in apoB length resulted in an approximately 13% decrease in core volume. These observations, which are in agreement with the observations of aberrant lipoproteins in hypobetalipoproteinemia, suggest that lipid recruitment by apoB is progressively reduced by carboxyl-terminal truncation. However, pulse-chase studies indicated that carboxyl-terminal truncation did not impair apoB secretion. The recombinant human apoB forms were secreted as efficiently as endogenous rat apoB100; approximately 20% of total newly synthesized apoB72, B80, or B100 was secreted at the end of the chase. Intracellular degradation of newly synthesized apoB was observed for both the truncated human and the endogenous rat proteins. These data suggest that the low apoB levels in hypobetalipoproteinemia might not be caused by impaired secretion of the truncated apoB proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300620

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

2.  Palmitoylation of apolipoprotein B is required for proper intracellular sorting and transport of cholesteroyl esters and triglycerides.

Authors:  Y Zhao; J B McCabe; J Vance; L G Berthiaume
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

3.  Measurement of apolipoprotein B in various cell lines: correlation between intracellular levels and rates of secretion.

Authors:  A Bakillah; Z Zhou; J Luchoomun; M M Hussain
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

4.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

5.  Murine mammary-derived cells secrete the N-terminal 41% of human apolipoprotein B on high density lipoprotein-sized lipoproteins containing a triacylglycerol-rich core.

Authors:  H Herscovitz; A Kritis; I Talianidis; E Zanni; V Zannis; D M Small
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

6.  Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.

Authors:  Shumei Zhong; Antonia Lucia Magnolo; Meenakshi Sundaram; Hu Zhou; Erik F Yao; Enza Di Leo; Paola Loria; Shuai Wang; Michelle Bamji-Mirza; Lisheng Wang; C Jamie McKnight; Daniel Figeys; Yuwei Wang; Patrizia Tarugi; Zemin Yao
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

7.  Hsp40s play distinct roles during the initial stages of apolipoprotein B biogenesis.

Authors:  Deepa Kumari; Edward A Fisher; Jeffrey L Brodsky
Journal:  Mol Biol Cell       Date:  2021-12-15       Impact factor: 3.612

8.  Endothelial progenitor cells display clonal restriction in multiple myeloma.

Authors:  Marc Braunstein; Tayfun Ozçelik; Sevgi Bağişlar; Varsha Vakil; Eric L P Smith; Kezhi Dai; Cemaliye B Akyerli; Olcay A Batuman
Journal:  BMC Cancer       Date:  2006-06-22       Impact factor: 4.430

Review 9.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

Review 10.  From Congenital Disorders of Fat Malabsorption to Understanding Intra-Enterocyte Mechanisms Behind Chylomicron Assembly and Secretion.

Authors:  Emile Levy; Jean François Beaulieu; Schohraya Spahis
Journal:  Front Physiol       Date:  2021-01-27       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.